TUESDAY, June 4 (HealthDay News) -- Aspirin appears to be just
as good as more expensive, more potent blood-thinning medication
for preventing blood clots after hip replacement surgery, according
to new research.
People who get artificial hips are at risk of serious blood
clots, such as deep vein thrombosis and pulmonary embolism, after
the surgery. To prevent them, doctors usually prescribe
blood-thinning (anticoagulant) medications, such as
low-molecular-weight heparin, which is given by injection, or the
newer drug, rivaroxaban (brand name Xarelto), a pill.
But that old medicine-cabinet standby, aspirin, also has
blood-thinning properties. And the Canadian researchers wondered if
this simple, inexpensive drug could also prevent blood clots after
a major surgery.
They compared the drugs for four weeks, following 10 days of
treatment with heparin immediately post-surgery.
The investigators found the two medications were similarly
effective and safe. Where the medicines differ significantly is in
"Low-molecular-weight heparin and the newer blood thinner, Xarelto, are similarly priced; they're several hundred-fold more expensive than aspirin," said the study's lead author, Dr. David Anderson, a professor and head of the department of medicine at Dalhousie University in Halifax, Nova Scotia.
"Given the low cost of aspirin and its convenience, it's a reasonable alternative to low-molecular-weight heparin when used in the manner designed in this trial," said Anderson.
Another expert said the study results, published in the June 4
issue of the
Annals of Internal Medicine, support previous observations.
"After initial treatment with an anticoagulant, then giving aspirin
to these patients for the prevention of [serious blood clots] is as
good," said Jawed Fareed, professor of pharmacology and pathology
and director of the hemostasis and thrombosis research unit at
Loyola University Medical Center in Maywood, Ill.
For the study, Anderson and his colleagues recruited 778
patients undergoing elective hip replacement surgery between 2007
and 2010. All received 10 days of heparin (dalteparin) following
surgery. After that, they were randomized into one of two groups
for four more weeks of blood-thinning therapy. Half continued
receiving heparin injections, while the other half took low-dose
(81 milligrams) aspirin daily.
Five people on dalteparin and one on aspirin developed a blood
clot. The absolute difference between the two therapies was 1
percent. Bleeding events serious enough to require treatment
occurred in five people on dalteparin, and two on aspirin.
Anderson said the difference in bleeding events wasn't
statistically significant, but there was a trend toward aspirin
being the safer alternative. However, it's too soon to tell
definitively whether aspirin might cause less bleeding, he
Anderson said the researchers had to stop the study early
because they weren't able to recruit the desired number of
patients. While the study was under way, Xarelto was approved, and
because it's a pill instead of an injectable like dalteparin (brand
name Fragmin), it became difficult to find volunteers for the
multiple injection part of the trial.
The researchers are now duplicating the study, but comparing
Xarelto to aspirin this time. They're also including people having
knee replacement surgery, and they're only using five days of
initial treatment with the more powerful blood-thinner.
"If aspirin turns out to be as good as Xarelto, given the number of joint [replacement] surgeries done in North America, it could save the health care system millions if it's proven to be at least as effective," said Anderson.
Fareed said he would not use aspirin immediately after the
surgery. "But once that initial phase settles down, I think aspirin
is a good option. And, I'm confident that the bleeding will be less
with aspirin," said Fareed.
He said doctors may not turn to aspirin right away, and would
probably wait until medical groups write new guidelines suggesting
aspirin as the standard of care. But it's certainly a topic that
patients could bring up with their doctor before surgery, he
"I think we have demonstrated that a very simple, inexpensive oral therapy appears to be as good as a more expensive, more potent, less convenient anticoagulant agent for the prevention of blood clots following total hip replacement," concluded Anderson.
The U.S. Agency for Healthcare Research and Quality has more on
preventing blood clots.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.